These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy. Lai TY; Lam CP; Luk FO; Chan RP; Chan WM; Liu DT; Lam DS J Ocul Pharmacol Ther; 2010 Feb; 26(1):91-5. PubMed ID: 20148658 [TBL] [Abstract][Full Text] [Related]
43. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy. Byeon SH; Lew YJ; Lee SC; Kwon OW Acta Ophthalmol; 2010 Sep; 88(6):660-8. PubMed ID: 19563374 [TBL] [Abstract][Full Text] [Related]
44. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy. Lee MW; Yeo I; Wong D; Ang CL Eye (Lond); 2009 Jun; 23(6):1417-22. PubMed ID: 18756283 [TBL] [Abstract][Full Text] [Related]
45. Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months. Hikichi T; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R; Takami K Am J Ophthalmol; 2010 Nov; 150(5):674-682.e1. PubMed ID: 20691424 [TBL] [Abstract][Full Text] [Related]
46. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan. Honda S; Imai H; Yamashiro K; Kurimoto Y; Kanamori-Matsui N; Kagotani Y; Tamura Y; Yamamoto H; Ohoto S; Takagi H; Uenishi M; Negi A Ophthalmologica; 2009; 223(5):333-8. PubMed ID: 19478533 [TBL] [Abstract][Full Text] [Related]
47. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions. Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H Retina; 2009; 29(7):960-5. PubMed ID: 19491727 [TBL] [Abstract][Full Text] [Related]
48. Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Akaza E; Yuzawa M; Mori R Jpn J Ophthalmol; 2011 Jan; 55(1):39-44. PubMed ID: 21331691 [TBL] [Abstract][Full Text] [Related]
49. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration. Lazic R; Gabric N Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776 [TBL] [Abstract][Full Text] [Related]
50. Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects. Rishi P; Rishi E; Sharma M; Maitray A; Bhende M; Gopal L; Sharma T; Ratra D; Sen P; Bhende P; Rao C; Susvar P Indian J Ophthalmol; 2017 Aug; 65(8):712-718. PubMed ID: 28820157 [TBL] [Abstract][Full Text] [Related]
51. Photodynamic therapy for polypoidal choroidal vasculopathy: baseline perimetric results and visual outcomes. Imasawa M; Tsumura T; Sekine A; Kikuchi T; Iijima H Jpn J Ophthalmol; 2009 Nov; 53(6):588-592. PubMed ID: 20020236 [TBL] [Abstract][Full Text] [Related]
52. Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation. Saito M; Iida T; Kano M Retina; 2011 Sep; 31(8):1589-97. PubMed ID: 21654347 [TBL] [Abstract][Full Text] [Related]
53. Photodynamic therapy for polypoidal choroidal vasculopathy. Chhablani JK Am J Ophthalmol; 2010 Nov; 150(5):754-5; author reply 755. PubMed ID: 21036213 [No Abstract] [Full Text] [Related]
54. One-year results of three monthly ranibizumab injections and as-needed reinjections for polypoidal choroidal vasculopathy in Japanese patients. Hikichi T; Higuchi M; Matsushita T; Kosaka S; Matsushita R; Takami K; Ohtsuka H; Ariga H Am J Ophthalmol; 2012 Jul; 154(1):117-124.e1. PubMed ID: 22465366 [TBL] [Abstract][Full Text] [Related]
56. Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area. Dewi NA; Yuzawa M; Tochigi K; Kawamura A; Mori R Jpn J Ophthalmol; 2008; 52(4):277-281. PubMed ID: 18773265 [TBL] [Abstract][Full Text] [Related]
58. Polypoidal choroidal vasculopathy in tilted disk syndrome and high myopia with staphyloma. Mauget-Faÿsse M; Cornut PL; Quaranta El-Maftouhi M; Leys A Am J Ophthalmol; 2006 Dec; 142(6):970-5. PubMed ID: 17046703 [TBL] [Abstract][Full Text] [Related]
59. Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Lai TY; Chan WM; Liu DT; Luk FO; Lam DS Br J Ophthalmol; 2008 May; 92(5):661-6. PubMed ID: 18356265 [TBL] [Abstract][Full Text] [Related]
60. Factors predictive of visual acuity outcomes 1 year after photodynamic therapy in Japanese patients with polypoidal choroidal vasculopathy. Hikichi T; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R; Takami K Retina; 2011 May; 31(5):857-65. PubMed ID: 21124252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]